Business

AI in Finance

Updated 2026-07-27 12:10 UTC 2 sources Neutral

Vasant Dhar, a pioneer of AI-driven hedge funds, discusses the technology's limitations. Meanwhile, RA Capital backs a new company competing with established players in rare disease treatments.

Coverage timeline — 2 articles

MarketWatch

He brought AI to Wall Street in 1994 — but won’t trust ChatGPT with his money

Vasant Dhar built one of the first AI-driven hedge funds. Here’s what he wants investors to know about the technology.

2026-07-27 11:50 UTC

STAT News

STAT+: RA Capital backs upstart rival to Ultragenyx and Ionis in rare brain disease

Oak Hill Bio, a new company backed by RA Capital and other investors, will take on Ultragenyx and Ionis in developing an Angelman syndrome medicine.

2026-07-27 12:00 UTC